Autotransfusion Devices Market Size, Share & Trends Analysis Report By Type (Autotransfusion Systems, Consumables& Accessories), By Application, By End Use (Hospitals & Clinics), By Region And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Autotransfusion Devices Market Trends
The global autotransfusion devices market size was estimated at USD 486.2 million in 2023 and is anticipated t%li%grow at a CAGR of 6.3% from 2024 t%li%2030. This growth is majorly driven by the increasing number of surgical procedures attributed t%li%the rising prevalence of lifestyle and chronic disease. According t%li%ISAPS global survey 2023 report published in June 2024, there was a significant increase of 5.5% in surgical procedures compared t%li%2022. Plastic surgeons performed over 15.8 million surgical procedures globally, indicating a growing demand for aesthetic surgeries.
Furthermore, the scarcity of donated blood or allogeneic blood is als%li%boosting the market's growth owing t%li%the extensive use of autotransfusion systems as they are highly useful in the purification of a patient's blood. For instance , according t%li%the data published by the American Red Cross Society in January 2022, the Red Cross has experienced a 10% decline in the number of people donating blood since the beginning of the pandemic.
The aging population is a significant factor driving the growth of the market. As the global population continues t%li%age, there is a growing demand for healthcare services and orthopedic surgery procedures, including surgeries that require blood transfusions. Chronic diseases such as coagulopathy, anemia, and surgical blood seeking continue t%li%increase along with the increase in the adult population. Currently, there are over 40 million people in the U.S. alone above 65 years and the number is expected t%li%double by 2050. Japan provides potential growth opportunities t%li%this market due t%li%the presence of the highest geriatric population in the country. According t%li%WHO, the percentage of the geriatric population is expected t%li%reach 22.0% by 2050.
Additionally, the growing strategic initiatives such as partnerships, mergers, and product approvals by market players t%li%develop autotransfusion devices and offer safe and effective auto-transfusion solutions are anticipated t%li%boost market growth in the forecast period. For instance, in March 2023, Haemonetics Corporation announced that it had obtained 510(k) clearance from the U.S. FDA for its latest software upgrade designed for the Cell Saver Elite+ autotransfusion system. This new software, named Intelligent Control, has been officially released t%li%the market, offering significant enhancements aimed at simplifying operations and improving user experience.
Furthermore, autotransfusion systems play a crucial role in managing intraoperative blood loss and promoting hemostasis during complex surgical procedures, thereby enhancing surgical outcomes and aiding in patient recovery. This, in turn, contributes t%li%the expansion of the market due t%li%the increasing demand for advanced surgical interventions including organ transplantation, oncology, and cardiovascular surgery. According t%li%the Organ Procurement and Transplantation Network study published in January 2024, there were a total of 46,632 organ transplants performed worldwide. This number includes transplants from both living and deceased donors. The total number of organ transplants in 2023 represents an 8.7 percent increase over the previous year, 2022, and a significant 12.7 percent increase over the year before that, which was 2021. It is worth noting that 2021 was the first year in which the total number of organ transplants exceeded 40,000.
Global Autotransfusion Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global autotransfusion devices market report based on type, application, end use and region.
Autotransfusion Devices Market Trends
The global autotransfusion devices market size was estimated at USD 486.2 million in 2023 and is anticipated t%li%grow at a CAGR of 6.3% from 2024 t%li%2030. This growth is majorly driven by the increasing number of surgical procedures attributed t%li%the rising prevalence of lifestyle and chronic disease. According t%li%ISAPS global survey 2023 report published in June 2024, there was a significant increase of 5.5% in surgical procedures compared t%li%2022. Plastic surgeons performed over 15.8 million surgical procedures globally, indicating a growing demand for aesthetic surgeries.
Furthermore, the scarcity of donated blood or allogeneic blood is als%li%boosting the market's growth owing t%li%the extensive use of autotransfusion systems as they are highly useful in the purification of a patient's blood. For instance , according t%li%the data published by the American Red Cross Society in January 2022, the Red Cross has experienced a 10% decline in the number of people donating blood since the beginning of the pandemic.
The aging population is a significant factor driving the growth of the market. As the global population continues t%li%age, there is a growing demand for healthcare services and orthopedic surgery procedures, including surgeries that require blood transfusions. Chronic diseases such as coagulopathy, anemia, and surgical blood seeking continue t%li%increase along with the increase in the adult population. Currently, there are over 40 million people in the U.S. alone above 65 years and the number is expected t%li%double by 2050. Japan provides potential growth opportunities t%li%this market due t%li%the presence of the highest geriatric population in the country. According t%li%WHO, the percentage of the geriatric population is expected t%li%reach 22.0% by 2050.
Additionally, the growing strategic initiatives such as partnerships, mergers, and product approvals by market players t%li%develop autotransfusion devices and offer safe and effective auto-transfusion solutions are anticipated t%li%boost market growth in the forecast period. For instance, in March 2023, Haemonetics Corporation announced that it had obtained 510(k) clearance from the U.S. FDA for its latest software upgrade designed for the Cell Saver Elite+ autotransfusion system. This new software, named Intelligent Control, has been officially released t%li%the market, offering significant enhancements aimed at simplifying operations and improving user experience.
Furthermore, autotransfusion systems play a crucial role in managing intraoperative blood loss and promoting hemostasis during complex surgical procedures, thereby enhancing surgical outcomes and aiding in patient recovery. This, in turn, contributes t%li%the expansion of the market due t%li%the increasing demand for advanced surgical interventions including organ transplantation, oncology, and cardiovascular surgery. According t%li%the Organ Procurement and Transplantation Network study published in January 2024, there were a total of 46,632 organ transplants performed worldwide. This number includes transplants from both living and deceased donors. The total number of organ transplants in 2023 represents an 8.7 percent increase over the previous year, 2022, and a significant 12.7 percent increase over the year before that, which was 2021. It is worth noting that 2021 was the first year in which the total number of organ transplants exceeded 40,000.
Global Autotransfusion Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 t%li%2030. For this study, Grand View Research has segmented the global autotransfusion devices market report based on type, application, end use and region.
- Type Outlook (Revenue, USD Million, 2018 - 2030)
- Autotransfusion Systems
- Intraoperative Autotransfusion Systems
- Post-operative Autotransfusion Systems
- Dual-mode Autotransfusion Systems
- Consumables & Accessories
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiaovascular Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Obstetrics & Gynecological Surgeries
- Others
- End use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ambulatory Surgical Centers
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Norway
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
CHAPTER 3. AUTOTRANSFUSION DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Autotransfusion Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. AUTOTRANSFUSION DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Autotransfusion Devices Market: Type Movement Analysis
4.3. Autotransfusion Devices Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Autotransfusion Systems
4.5.1. Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Intraoperative Autotransfusion Systems
4.5.2.1. Intraoperative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Post-operative Autotransfusion Systems
4.5.3.1. Post-operative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Dual-mode Autotransfusion Systems
4.5.4.1. Dual-mode Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Consumables & Accessories
4.6.1. Consumables & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. AUTOTRANSFUSION DEVICES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Autotransfusion Devices Market: Application Movement Analysis
5.3. Autotransfusion Devices Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Cardiaovascular Surgeries
5.5.1. Cardiaovascular Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Orthopedic Surgeries
5.6.1. Orthopedic Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Neurological Surgeries
5.7.1. Neurological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Obstetrics & Gynecological Surgeries
5.8.1. Obstetrics & Gynecological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. AUTOTRANSFUSION DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Autotransfusion Devices Market: End use Movement Analysis
6.3. Autotransfusion Devices Market by End use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals and Clinics
6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Ambulatory Surgical Centres
6.6.1. Ambulatory Surgical Centres Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. AUTOTRANSFUSION DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Dashboard
7.2. Regional Autotransfusion Devices Market movement analysis
7.3. Autotransfusion Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Atrium Orthopedic Surgeries Corporation
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Becton, Dickinson, and Company
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Beijing ZKSK Technology Co. Ltd
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Fresenius SE & Co. KGA
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. LivaNova Inc
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic plc
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Teleflex Incorporated
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Haematonics Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Braile Biomedica
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Redax
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Type
1.1.2. Application
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Regional outlook
2.4. Competitive Insights
CHAPTER 3. AUTOTRANSFUSION DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Autotransfusion Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. AUTOTRANSFUSION DEVICES MARKET: TYPE ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Autotransfusion Devices Market: Type Movement Analysis
4.3. Autotransfusion Devices Market by Type Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Autotransfusion Systems
4.5.1. Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.2. Intraoperative Autotransfusion Systems
4.5.2.1. Intraoperative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.3. Post-operative Autotransfusion Systems
4.5.3.1. Post-operative Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5.4. Dual-mode Autotransfusion Systems
4.5.4.1. Dual-mode Autotransfusion Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Consumables & Accessories
4.6.1. Consumables & Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. AUTOTRANSFUSION DEVICES MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Autotransfusion Devices Market: Application Movement Analysis
5.3. Autotransfusion Devices Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Cardiaovascular Surgeries
5.5.1. Cardiaovascular Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Orthopedic Surgeries
5.6.1. Orthopedic Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Neurological Surgeries
5.7.1. Neurological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Obstetrics & Gynecological Surgeries
5.8.1. Obstetrics & Gynecological Surgeries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. AUTOTRANSFUSION DEVICES MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Autotransfusion Devices Market: End use Movement Analysis
6.3. Autotransfusion Devices Market by End use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals and Clinics
6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Ambulatory Surgical Centres
6.6.1. Ambulatory Surgical Centres Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. AUTOTRANSFUSION DEVICES MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Dashboard
7.2. Regional Autotransfusion Devices Market movement analysis
7.3. Autotransfusion Devices Market: Regional Estimates & Trend Analysis by Technology & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement scenario
7.5.7.5. UK Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement scenario
7.5.8.5. Germany Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement scenario
7.5.9.5. France Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Reimbursement scenario
7.5.10.5. Italy Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Reimbursement scenario
7.5.11.5. Spain Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Reimbursement scenario
7.5.12.5. Denmark Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Reimbursement scenario
7.5.13.5. Sweden Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Reimbursement scenario
7.5.14.5. Norway Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. Japan Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. China Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. India Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. South Korea Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Australia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Thailand Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Brazil Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. Argentina Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. South Africa Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Saudi Arabia Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement scenario
7.8.4.5. UAE Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement scenario
7.8.5.5. Kuwait Autotransfusion Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Atrium Orthopedic Surgeries Corporation
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Becton, Dickinson, and Company
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Beijing ZKSK Technology Co. Ltd
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Fresenius SE & Co. KGA
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. LivaNova Inc
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Medtronic plc
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Teleflex Incorporated
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Haematonics Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Braile Biomedica
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Redax
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
LIST OF TABLES
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 4. Global autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 5. Global autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 6. North America autotransfusion devices market, by region, 2018 - 2030 (USD Million)
Table 7. North America autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 8. North America autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 9. North America autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 10. U.S. autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 11. U.S. autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 12. U.S. autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 13. Mexico autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 14. Mexico autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 15. Mexico autotransfusion devices market, by end use, 2018-2030, (USD Million
Table 16. Canada autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 17. Canada autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 18. Canada autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 19. Europe autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 20. Europe autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 21. Europe autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 22. Europe autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 23. UK autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 24. UK autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 25. UK autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 26. Germany autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 27. Germany autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 28. Germany autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 29. France autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 30. France autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 31. France autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 32. Italy autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 33. Italy autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 34. Italy autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 35. Spain autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 36. Spain autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 37. Spain autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 38. Norway autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 39. Norway autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 40. Norway autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 41. Sweden autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 42. Sweden autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 43. Sweden autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 44. Denmark autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 45. Denmark autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 46. Denmark autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 49. Asia Pacific autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 51. Japan autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 52. Japan autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 53. Japan autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 54. China autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 55. China autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 56. China autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 57. India autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 58. India autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 59. India autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 60. Australia autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 61. Australia autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 62. Australia autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 63. South Korea autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 64. South Korea autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 65. South Korea autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 66. Thailand autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 67. Thailand autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 68. Thailand autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 69. Latin America autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 71. Latin America autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 72. Latin America autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 73. Brazil autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 74. Brazil autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 75. Brazil autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 76. Argentina autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 77. Argentina autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 78. Argentina autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 83. South Africa autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 84. South Africa autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 85. South Africa autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 89. UAE autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 90. UAE autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 91. UAE autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 92. Kuwait autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 93. Kuwait autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 94. Kuwait autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 4. Global autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 5. Global autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 6. North America autotransfusion devices market, by region, 2018 - 2030 (USD Million)
Table 7. North America autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 8. North America autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 9. North America autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 10. U.S. autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 11. U.S. autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 12. U.S. autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 13. Mexico autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 14. Mexico autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 15. Mexico autotransfusion devices market, by end use, 2018-2030, (USD Million
Table 16. Canada autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 17. Canada autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 18. Canada autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 19. Europe autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 20. Europe autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 21. Europe autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 22. Europe autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 23. UK autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 24. UK autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 25. UK autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 26. Germany autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 27. Germany autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 28. Germany autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 29. France autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 30. France autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 31. France autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 32. Italy autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 33. Italy autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 34. Italy autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 35. Spain autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 36. Spain autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 37. Spain autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 38. Norway autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 39. Norway autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 40. Norway autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 41. Sweden autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 42. Sweden autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 43. Sweden autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 44. Denmark autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 45. Denmark autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 46. Denmark autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 49. Asia Pacific autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 50. Asia Pacific autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 51. Japan autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 52. Japan autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 53. Japan autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 54. China autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 55. China autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 56. China autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 57. India autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 58. India autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 59. India autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 60. Australia autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 61. Australia autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 62. Australia autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 63. South Korea autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 64. South Korea autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 65. South Korea autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 66. Thailand autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 67. Thailand autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 68. Thailand autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 69. Latin America autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 71. Latin America autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 72. Latin America autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 73. Brazil autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 74. Brazil autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 75. Brazil autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 76. Argentina autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 77. Argentina autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 78. Argentina autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa autotransfusion devices market, by country, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 83. South Africa autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 84. South Africa autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 85. South Africa autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 89. UAE autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 90. UAE autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 91. UAE autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
Table 92. Kuwait autotransfusion devices market, by type, 2018 - 2030 (USD Million)
Table 93. Kuwait autotransfusion devices market, by application, 2018 - 2030 (USD Million)
Table 94. Kuwait autotransfusion devices market, by end use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Dermatology imaging devices market: Market outlook
Fig. 14 Dermatology imaging devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging restraint impact
Fig. 21 Preclinical imaging market: product movement analysis
Fig. 22 Preclinical imaging market: product outlook and key takeaways
Fig. 23 CT market estimates and forecast, 2018 - 2030
Fig. 24 MRI market estimates and forecast, 2018 - 2030
Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
Fig. 27 Optical market estimates and forecast, 2018 - 2030
Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
Fig. 30 Reagents market estimates and forecast, 2018 - 2030
Fig. 31 Services market estimates and forecast, 2018 - 2030
Fig. 32 Preclinical imaging market: application movement analysis
Fig. 33 Preclinical imaging market: application outlook and key takeaways
Fig. 34 Research and development market estimates and forecast, 2018 - 2030
Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
Fig. 36 Preclinical imaging market: end use movement analysis
Fig. 37 Preclinical imaging market: end use outlook and key takeaways
Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
Fig. 40 Global Dermatology imaging devices market: regional movement analysis
Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030
Fig. 48 Mexico
Fig. 49 Mexico market estimates and forecast, 2018 - 2030
Fig. 50 Europe
Fig. 51 Europe. market estimates and forecast, 2018 - 2030
Fig. 52 UK
Fig. 53 UK market estimates and forecast, 2018 - 2030
Fig. 54 Germany
Fig. 55 Germany market estimates and forecast, 2018 - 2030
Fig. 56 France
Fig. 57 France market estimates and forecast, 2018 - 2030
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018 - 2030
Fig. 62 Denmark
Fig. 63 Denmark market estimates and forecast, 2018 - 2030
Fig. 64 Sweden
Fig. 65 Sweden market estimates and forecast, 2018 - 2030
Fig. 66 Norway
Fig. 67 Norway market estimates and forecast, 2018 - 2030
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 70 Japan
Fig. 71 Japan market estimates and forecast, 2018 - 2030
Fig. 72 China
Fig. 73 China market estimates and forecast, 2018 - 2030
Fig. 74 India
Fig. 75 India market estimates and forecast, 2018 - 2030
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecast, 2018 - 2030
Fig. 78 Thailand
Fig. 79 Thailand market estimates and forecast, 2018 - 2030
Fig. 80 Australia
Fig. 81 Australia market estimates and forecast, 2018 - 2030
Fig. 82 Latin America
Fig. 83 Latin America market estimates and forecast, 2018 - 2030
Fig. 84 Brazil
Fig. 85 Brazil market estimates and forecast, 2018 - 2030
Fig. 86 Argentina
Fig. 87 Argentina market estimates and forecast, 2018 - 2030
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 90 Saudi Arabia
Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 92 South Africa
Fig. 93 South Africa market estimates and forecast, 2018 - 2030
Fig. 94 UAE
Fig. 95 UAE market estimates and forecast, 2018 - 2030
Fig. 96 Kuwait
Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
Fig. 98 Participant categorization- Preclinical imaging market
Fig. 99 Market share of key market players- Preclinical imaging market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Dermatology imaging devices market: Market outlook
Fig. 14 Dermatology imaging devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging restraint impact
Fig. 21 Preclinical imaging market: product movement analysis
Fig. 22 Preclinical imaging market: product outlook and key takeaways
Fig. 23 CT market estimates and forecast, 2018 - 2030
Fig. 24 MRI market estimates and forecast, 2018 - 2030
Fig. 25 PET/SPECT market estimates and forecast, 2018 - 2030
Fig. 26 Multi Modal market estimates and forecast, 2018 - 2030
Fig. 27 Optical market estimates and forecast, 2018 - 2030
Fig. 28 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 29 Photoacoustic market estimates and forecast, 2018 - 2030
Fig. 30 Reagents market estimates and forecast, 2018 - 2030
Fig. 31 Services market estimates and forecast, 2018 - 2030
Fig. 32 Preclinical imaging market: application movement analysis
Fig. 33 Preclinical imaging market: application outlook and key takeaways
Fig. 34 Research and development market estimates and forecast, 2018 - 2030
Fig. 35 Drug discovery market estimates and forecast, 2018 - 2030
Fig. 36 Preclinical imaging market: end use movement analysis
Fig. 37 Preclinical imaging market: end use outlook and key takeaways
Fig. 38 Pharma and biotech companies market estimates and forecast, 2018 - 2030
Fig. 39 Research institutes market estimates and forecast, 2018 - 2030
Fig. 40 Global Dermatology imaging devices market: regional movement analysis
Fig. 41 Global Dermatology imaging devices market: regional outlook and key takeaways
Fig. 42 North America
Fig. 43 North America market estimates and forecast, 2018 - 2030
Fig. 44 U.S.
Fig. 45 U.S. market estimates and forecast, 2018 - 2030
Fig. 46 Canada
Fig. 47 Canada market estimates and forecast, 2018 - 2030
Fig. 48 Mexico
Fig. 49 Mexico market estimates and forecast, 2018 - 2030
Fig. 50 Europe
Fig. 51 Europe. market estimates and forecast, 2018 - 2030
Fig. 52 UK
Fig. 53 UK market estimates and forecast, 2018 - 2030
Fig. 54 Germany
Fig. 55 Germany market estimates and forecast, 2018 - 2030
Fig. 56 France
Fig. 57 France market estimates and forecast, 2018 - 2030
Fig. 58 Italy
Fig. 59 Italy market estimates and forecast, 2018 - 2030
Fig. 60 Spain
Fig. 61 Spain market estimates and forecast, 2018 - 2030
Fig. 62 Denmark
Fig. 63 Denmark market estimates and forecast, 2018 - 2030
Fig. 64 Sweden
Fig. 65 Sweden market estimates and forecast, 2018 - 2030
Fig. 66 Norway
Fig. 67 Norway market estimates and forecast, 2018 - 2030
Fig. 68 Asia Pacific
Fig. 69 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 70 Japan
Fig. 71 Japan market estimates and forecast, 2018 - 2030
Fig. 72 China
Fig. 73 China market estimates and forecast, 2018 - 2030
Fig. 74 India
Fig. 75 India market estimates and forecast, 2018 - 2030
Fig. 76 South Korea
Fig. 77 South Korea market estimates and forecast, 2018 - 2030
Fig. 78 Thailand
Fig. 79 Thailand market estimates and forecast, 2018 - 2030
Fig. 80 Australia
Fig. 81 Australia market estimates and forecast, 2018 - 2030
Fig. 82 Latin America
Fig. 83 Latin America market estimates and forecast, 2018 - 2030
Fig. 84 Brazil
Fig. 85 Brazil market estimates and forecast, 2018 - 2030
Fig. 86 Argentina
Fig. 87 Argentina market estimates and forecast, 2018 - 2030
Fig. 88 Middle East and Africa
Fig. 89 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 90 Saudi Arabia
Fig. 91 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 92 South Africa
Fig. 93 South Africa market estimates and forecast, 2018 - 2030
Fig. 94 UAE
Fig. 95 UAE market estimates and forecast, 2018 - 2030
Fig. 96 Kuwait
Fig. 97 Kuwait market estimates and forecast, 2018 - 2030
Fig. 98 Participant categorization- Preclinical imaging market
Fig. 99 Market share of key market players- Preclinical imaging market
